Scientists have genetically engineered tobacco plants to produce a protein for a vaccine against amoebiasis — a disease predominantly affecting Central and South America, Africa and Asia. The World Health Organization estimates that amoebiasis, caused by the parasite Entamoeba hisolytica, causes 50 million cases and 100,000 deaths a year. There is currently no approved vaccine against the disease.